HomeInsightsEPS

Concord Drugs Ltd EPS

Concord Drugs Ltd EPS

stocks purchased

₹ 0.0 Cr

Volume Transacted

(Dec 12, 2024)

stocks purchased

0.9 K

Stocks Traded

(Dec 12, 2024)

Last Updated on: Dec 12, 2024

Image

Concord Drugs Ltd

NSE: CONCORDDRUGS

EPS

₹ -0.51

Last updated on: Dec 11, 2024

Key Highlights

  • The Earning per Share of Concord Drugs Ltd is ₹ -0.51 as of 11 Dec 24 .
  • The earning per share of Concord Drugs Ltd changed from ₹ 0.21 to ₹ 0.04 over 10 quarters. This represents a CAGR of -48.48% .

Historical Earning per Share of Concord Drugs Ltd

No data available

* All values are in

Company Fundamentals for Concord Drugs Ltd

Market Cap

36 Cr

EPS

0.0

P/E Ratio (TTM) *

0.0

P/B Ratio (TTM) *

1.1

Day’s High *

38.84

Day’s Low

36.26

DTE *

0.6

ROE *

-1.5

52 Week High

61.5

52 Week Low

30.59

ROCE *

2.3

Market Price of Concord Drugs Ltd

1M

1Y

3Y

5Y

Monitoring Concord Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
11 Dec 202436.87
10 Dec 202437.71
09 Dec 202437.98
06 Dec 202437.86
05 Dec 202438.01
04 Dec 202438.23
03 Dec 202437.34
02 Dec 202435
29 Nov 202435
28 Nov 202435.35

BlinkX Score for Concord Drugs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Concord Drugs Ltd

Market Value

37

-0.2 X

Value addition

Asset Value

45

* All values are in Rupees

Competitive Comparison of EPS

Company NameEPSMarket Cap (INR Cr.)
Concord Drugs Ltd036
Sun Pharmaceuticals Industries Ltd464,35,407
Divis Laboratories Ltd691,57,489
Cipla Ltd571,17,443
Torrent Pharmaceuticals Ltd511,14,197
Mankind Pharma Ltd521,05,098

Historical Market Cap of Concord Drugs Ltd

No data available

* All values are in crore

Historical Revenue of Concord Drugs Ltd

No data available

* All values are in crore

Historical EBITDA of Concord Drugs Ltd

No data available

* All values are in crore

Historical Net Profit of Concord Drugs Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Concord Drugs Ltd News Hub

News

Concord Drugs announces board meeting date

Concord Drugs will hold a meeting of the Board of Directors of the Company on 13 November ...

Read more

08 Nov 2024 12:33

News

Concord Drugs to conduct AGM

Concord Drugs announced that the Annual General Meeting (AGM) of the company will be held ...

Read more

19 Sep 2024 17:57

News

Concord Drugs schedules AGM

Concord Drugs announced that the Annual General Meeting (AGM) of the company will be held ...

Read more

19 Sep 2024 10:06

News

Concord Drugs fixes board meeting date

Concord Drugs will hold a meeting of the Board of Directors of the Company on 6 September ...

Read more

03 Sep 2024 11:10

News

Concord Drugs to table results

Concord Drugs will hold a meeting of the Board of Directors of the Company on 9 August 202...

Read more

06 Aug 2024 16:20

News

Concord Drugs postpones board meeting

Concord Drugs has postponed the meeting of the Board of Directors which was scheduled to b...

Read more

25 May 2024 11:26

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of Concord Drugs Ltd

What is the EPS of Concord Drugs Ltd stock?

The Earnings Per Share (EPS) of Concord Drugs Ltd is 0.0. An EPS is the amount of net income attributed to each share of a common stock.

How is Concord Drugs Ltd EPS calculated?

The EPS of Concord Drugs Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Concord Drugs Ltd report its EPS?

Concord Drugs Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Concord Drugs Ltd EPS?

Factors that influence the EPS of Concord Drugs Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Concord Drugs Ltd EPS growth indicate future performance?

Yes, consistent growth in Concord Drugs Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions